Searched for
STRIDES SHASUN GROUP
Strides Shasun Q4 loss at Rs 4.40 cr, shares tank 23%The company had posted a net profit of Rs 91.59 crore for the same period a year ago.- Strides Shasun gets USFDA nod for generic Ibuprofen capsulesThe generic Ibuprofen capsules, 200 mg, is meant for relieving pain and will be manufactured at the company's oral dosage facility in Banga...
- Blackstone, Strides, Nectar lead race for Orchid PharmaShares of Orchid closed at Rs 17 on Friday, down 5 per cent.
- Eris signs definitive pact to buy Strides’ India portfolio for Rs 500 crThe acquisition is Eris’s fourth and the largest buyout in the last 18 months. With this, the company will be among the top ten companies i...
- Eris Life to acquire Strides' India business for Rs 500 croreBoards of both the companies are expected to meet on Saturday and a formal announcement is due as early as on Monday, people with knowledge...
- Top stocks in focus on Friday, 1 September 2017Here is a list of top stocks that are likely to be in focus in today's trading session.
- Strides Shasun's plant completes successful USFDA inspectionThe company remains committed to meeting the expectation of the authorities in the challenging regulatory landscape as it continues to evol...
- Strides Shasun Q3 net jumps over 3 fold; plans restructuringThe company had posted a net profit after taxes and minority interest and share of loss of associates and joint ventures of
- Better valuations: Midcaps and smallcaps can do all the running this year tooInvestors might need to be choosy as the rally in smaller shares is unlikely to be broad-based as earnings prospects of several companies h...
- Strides Shasun to acquire Perrigo API India for Rs 100 croreThe transaction is subject to customary closing conditions and expected to be closed by December 31, 2016, Strides told the Bombay Stock Ex...
- OrbiMed to invest $40 million in Suraksha DiagnosticsSuraksha, promoted by Panorama Group, operates more than 30 centres including polyclinics and has expanded services to include cardiology ,...
- Strides Shasun plans to divest British subsidiary for Rs 240 croreThe supply agreement is an extension to the existing supply arrangement previously in place between Pharmacy Alliance and Aspen.
- Twelve stocks in focus in Tuesday morning tradeThe Indian market is expected to trade in a range. Here is a list of top twelve stocks that are likely to be in focus today.
- Strides Shasun suspends production at Cuddalore unit block on govt ordersThe pharma company said that the company is working with the authorities to resume operations at the earliest.
- Government approves FDI worth Rs 4,000 crore by four pharma firmsTorrent Pharmaceuticals' proposal for increasing FII investment limit to 35 per cent from 13.09 per cent was the biggest in terms of value ...
- Strides Arcolab to get product pipeline developed by AspenStrides Arcolab has said its deal with Aspen Pharmacare to buy the latter's Australia assets will help the Indian drug company rebuild its ...
- Drug firm Strides Arcolab reports Q4 net profit at Rs 69.66 croreThe company had posted a net loss of Rs 48.26 crore for the corresponding period of the previous fiscal, Strides Arcolab said.
- Strides Arcolab posts Rs 338 crore profit in Q2Net sales rose to Rs 201.35 crore for the second quarter of this year from Rs 199.18 crore in the same period of the previous year, Strides...
- Strides Arcolab set to acquire Shasun Pharma in an all-stock dealShareholders of Chennai-based Shasun Pharma will receive five equity shares of Strides for every 16 equity shares they hold in the company.
- Strides, Shasun announce merger; to create Rs 2,500 crore entityBased on the exchange ratio, Shasun shareholders will own 26 per cent of the combined entity.
Load More
